Strategy for Adequate Blood Pressure Lowering in the Patients With Intracranial Atherosclerosis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 132 participants.
Also called NCT01104311
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 132 participants
- Sponsor
- Registry
-
NCT01104311
-
- Other papers using this trial's data
- Intensive blood pressure control may not be safe in subacute ischemic stroke by intracranial atherosclerosis: a result of randomized trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- South Korea
- Registry status
- Terminated
Technical summary
Registry record NCT01104311. Randomized; single masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-04 (actual). Results posted on 2017-03-07.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Strategy for Adequate Blood Pressure Lowering in the Patients With Intracranial Atherosclerosis
- Acronym
- STABLE-ICAS
- Condition
- Brain Ischemia
- Intervention (Procedure)
- Aggressive BP lowering
- Intervention (Procedure)
- modest blood pressure lowering
- Lead sponsor
- Asan Medical Center
- Collaborator
- Pfizer
Record details
- Record id
cardio:ct-nct01104311- Content hash
7b5cea4307404b67966b1665ca6542d6b3e047853f67bbbee2cc5dbe6b198e11